NovaBay Pharmaceuticals, Inc. (NBY) Social Stream
NOVABAY PHARMACEUTICALS INC (NBY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NBY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-13 | 1 | $2.2 | $2.2 | $2.2 | $0.176 | 1150% |
| 2022-05-20 | 1 | $4 | $2.2 | $3.1 | $0.176 | 1661.36% |
| 2022-09-20 | 1 | $139.86 | $64.685 | $102.272 | $0.176 | 58009.09% |
| 2022-11-30 | 1 | $139.86 | $15 | $77.43 | $0.176 | 43894.32% |
| 2023-05-15 | 1 | $6 | $6 | $6 | $0.176 | 3309.09% |
| 2023-08-11 | 1 | $3.8 | $3.8 | $3.8 | $0.176 | 2059.09% |
Price Target Last Issued September 20, 2022
The Trend in the Analyst Price Target
NBY's average price target has moved up $1.6 over the prior 17 months.
Over the past 88 days, NBY's average upside potential has been 572.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-15 | 1 | 6.0 | 6.0 | 6.0 | 0.767 | 682.27% |
| 2023-08-11 | 1 | 3.8 | 3.8 | 3.8 | 0.676 | 462.13% |
NBY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 21 months, NBY's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NBY as an investment opportunity.
- NBY has a higher number of analysts covering the stock than nearly none of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, NOVABAY PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 692.47% of them.
- NOVABAY PHARMACEUTICALS INC's average analyst price target is greater than 187.51% of Pharmaceutical Products stocks.
- NOVABAY PHARMACEUTICALS INC's variance in analysts' estimates is lower than -229.14% of stocks in the micro market cap category.
In the Pharmaceutical Products industry, SNOA, OGEN, and NBSE are the three stocks most similar to NOVABAY PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding NBY using the data that counts. Try POWR Ratings for free.